PDB Short entry for 3DAB HEADER CELL CYCLE 29-MAY-08 3DAB TITLE STRUCTURE OF THE HUMAN MDMX PROTEIN BOUND TO THE P53 TUMOR SUPPRESSOR TITLE 2 TRANSACTIVATION DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: MDM4 PROTEIN; COMPND 3 CHAIN: A, C, E, G; COMPND 4 FRAGMENT: UNP RESIDUES 23-111; COMPND 5 SYNONYM: P53-BINDING PROTEIN MDM4, MDM2-LIKE P53-BINDING PROTEIN, COMPND 6 PROTEIN MDMX, DOUBLE MINUTE 4 PROTEIN; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: CELLULAR TUMOR ANTIGEN P53; COMPND 10 CHAIN: B, D, F, H; COMPND 11 FRAGMENT: UNP RESIDUES 15-29; COMPND 12 SYNONYM: TUMOR SUPPRESSOR P53, PHOSPHOPROTEIN P53, ANTIGEN NY-CO-13; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MDM4, MDMX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL-21 RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-46; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: SYNTHETIC HUMAN P53 PEPTIDE KEYWDS MDMX, MDM4, HDMX, HDM4, MDM-4, MDM-X, MDM2, HDM2, P53, TUMOR, KEYWDS 2 NUCLEUS, ONCOGENE, APOPTOSIS, CELL CYCLE, DISEASE MUTATION, DNA- KEYWDS 3 BINDING, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR G.M.POPOWICZ,A.CZARNA,T.A.HOLAK REVDAT 5 01-NOV-23 3DAB 1 REMARK REVDAT 4 06-NOV-19 3DAB 1 JRNL SEQADV REVDAT 3 25-OCT-17 3DAB 1 REMARK REVDAT 2 24-FEB-09 3DAB 1 VERSN REVDAT 1 02-SEP-08 3DAB 0 JRNL AUTH G.M.POPOWICZ,A.CZARNA,T.A.HOLAK JRNL TITL STRUCTURE OF THE HUMAN MDMX PROTEIN BOUND TO THE P53 TUMOR JRNL TITL 2 SUPPRESSOR TRANSACTIVATION DOMAIN. JRNL REF CELL CYCLE V. 7 2441 2008 JRNL REFN ESSN 1551-4005 JRNL PMID 18677113 JRNL DOI 10.4161/CC.6365 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 30432 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1626 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.95 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2029 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.03 REMARK 3 BIN R VALUE (WORKING SET) : 0.2240 REMARK 3 BIN FREE R VALUE SET COUNT : 82 REMARK 3 BIN FREE R VALUE : 0.2750 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3151 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 429 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.33 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.99000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : -1.06000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.49000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.180 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.171 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.120 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.930 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3215 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2168 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4343 ; 1.354 ; 1.986 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5332 ; 1.089 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 386 ;10.365 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 144 ;43.988 ;25.000 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 585 ;14.745 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;18.242 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 486 ; 0.127 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3474 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 598 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 702 ; 0.207 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2169 ; 0.184 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1501 ; 0.181 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1582 ; 0.085 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 255 ; 0.163 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 15 ; 0.351 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 32 ; 0.269 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 33 ; 0.183 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2036 ; 0.850 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 788 ; 0.161 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3143 ; 1.261 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1362 ; 1.861 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1200 ; 2.722 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3DAB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 02-JUN-08. REMARK 100 THE DEPOSITION ID IS D_1000047789. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(111) MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31292 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.19500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 7.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1YCR REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.15 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG3350, 0.1M MES, PH6.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 300K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.43500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5850 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -11.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 930 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1110 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 5860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 110 REMARK 465 THR A 111 REMARK 465 SER B 15 REMARK 465 GLN B 16 REMARK 465 ASN B 29 REMARK 465 THR C 108 REMARK 465 LEU C 109 REMARK 465 ALA C 110 REMARK 465 THR C 111 REMARK 465 SER D 15 REMARK 465 GLN D 16 REMARK 465 GLU D 28 REMARK 465 ASN D 29 REMARK 465 THR E 108 REMARK 465 LEU E 109 REMARK 465 ALA E 110 REMARK 465 THR E 111 REMARK 465 SER F 15 REMARK 465 GLU F 28 REMARK 465 ASN F 29 REMARK 465 ALA G 110 REMARK 465 THR G 111 REMARK 465 SER H 15 REMARK 465 GLN H 16 REMARK 465 GLU H 17 REMARK 465 ASN H 29 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 50 CD CE NZ REMARK 470 GLN A 69 CG CD OE1 NE2 REMARK 470 LYS A 93 CE NZ REMARK 470 LYS A 104 NZ REMARK 470 LYS B 24 CE NZ REMARK 470 LYS C 30 CE NZ REMARK 470 MET C 46 CG SD CE REMARK 470 LYS C 50 CD CE NZ REMARK 470 LYS C 93 CE NZ REMARK 470 LYS C 104 NZ REMARK 470 GLU D 17 CG CD OE1 OE2 REMARK 470 LYS E 50 CD CE NZ REMARK 470 LYS E 104 NZ REMARK 470 LYS F 24 CD CE NZ REMARK 470 ILE G 24 CD1 REMARK 470 LYS G 50 CD CE NZ REMARK 470 LYS G 93 CE NZ REMARK 470 LYS G 104 NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 584 O HOH E 630 2645 2.05 REMARK 500 OE2 GLU A 83 CG2 THR D 18 1545 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLN F 16 N - CA - C ANGL. DEV. = 16.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 45 14.50 -143.09 REMARK 500 GLN E 26 50.43 -143.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Z5S RELATED DB: PDB REMARK 900 STRUCTURE OF ZEBRAFISH MDMX WITH HUMAN P53 PEPTIDE REMARK 900 RELATED ID: 2Z5T RELATED DB: PDB REMARK 900 STRUCTURE OF ZEBRAFISH MDMX MUTATED TO MIMIC HUMAN WITH HUMAN P53 REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1YCR RELATED DB: PDB REMARK 900 STRUCTURE OF ANALOGOUS MDM2 PROTEIN REMARK 900 RELATED ID: 1T4F RELATED DB: PDB REMARK 900 STRUCTURE OF ANALOGOUS MDM2 PROTEIN REMARK 900 RELATED ID: 3DAC RELATED DB: PDB REMARK 900 STRUCTURE OF ZEBRAFISH MDMX MUTATED TO MIMIC HUMAN WITH LONGER REMARK 900 HUMAN P53 PEPTIDE DBREF 3DAB A 23 111 UNP O15151 MDM4_HUMAN 23 111 DBREF 3DAB B 15 29 UNP P04637 P53_HUMAN 15 29 DBREF 3DAB C 23 111 UNP O15151 MDM4_HUMAN 23 111 DBREF 3DAB D 15 29 UNP P04637 P53_HUMAN 15 29 DBREF 3DAB E 23 111 UNP O15151 MDM4_HUMAN 23 111 DBREF 3DAB F 15 29 UNP P04637 P53_HUMAN 15 29 DBREF 3DAB G 23 111 UNP O15151 MDM4_HUMAN 23 111 DBREF 3DAB H 15 29 UNP P04637 P53_HUMAN 15 29 SEQADV 3DAB ILE A 500 UNP O15151 EXPRESSION TAG SEQADV 3DAB ILE C 500 UNP O15151 EXPRESSION TAG SEQADV 3DAB ILE E 500 UNP O15151 EXPRESSION TAG SEQADV 3DAB ILE G 500 UNP O15151 EXPRESSION TAG SEQRES 1 A 90 ILE GLN ILE ASN GLN VAL ARG PRO LYS LEU PRO LEU LEU SEQRES 2 A 90 LYS ILE LEU HIS ALA ALA GLY ALA GLN GLY GLU MET PHE SEQRES 3 A 90 THR VAL LYS GLU VAL MET HIS TYR LEU GLY GLN TYR ILE SEQRES 4 A 90 MET VAL LYS GLN LEU TYR ASP GLN GLN GLU GLN HIS MET SEQRES 5 A 90 VAL TYR CYS GLY GLY ASP LEU LEU GLY GLU LEU LEU GLY SEQRES 6 A 90 ARG GLN SER PHE SER VAL LYS ASP PRO SER PRO LEU TYR SEQRES 7 A 90 ASP MET LEU ARG LYS ASN LEU VAL THR LEU ALA THR SEQRES 1 B 15 SER GLN GLU THR PHE SER ASP LEU TRP LYS LEU LEU PRO SEQRES 2 B 15 GLU ASN SEQRES 1 C 90 ILE GLN ILE ASN GLN VAL ARG PRO LYS LEU PRO LEU LEU SEQRES 2 C 90 LYS ILE LEU HIS ALA ALA GLY ALA GLN GLY GLU MET PHE SEQRES 3 C 90 THR VAL LYS GLU VAL MET HIS TYR LEU GLY GLN TYR ILE SEQRES 4 C 90 MET VAL LYS GLN LEU TYR ASP GLN GLN GLU GLN HIS MET SEQRES 5 C 90 VAL TYR CYS GLY GLY ASP LEU LEU GLY GLU LEU LEU GLY SEQRES 6 C 90 ARG GLN SER PHE SER VAL LYS ASP PRO SER PRO LEU TYR SEQRES 7 C 90 ASP MET LEU ARG LYS ASN LEU VAL THR LEU ALA THR SEQRES 1 D 15 SER GLN GLU THR PHE SER ASP LEU TRP LYS LEU LEU PRO SEQRES 2 D 15 GLU ASN SEQRES 1 E 90 ILE GLN ILE ASN GLN VAL ARG PRO LYS LEU PRO LEU LEU SEQRES 2 E 90 LYS ILE LEU HIS ALA ALA GLY ALA GLN GLY GLU MET PHE SEQRES 3 E 90 THR VAL LYS GLU VAL MET HIS TYR LEU GLY GLN TYR ILE SEQRES 4 E 90 MET VAL LYS GLN LEU TYR ASP GLN GLN GLU GLN HIS MET SEQRES 5 E 90 VAL TYR CYS GLY GLY ASP LEU LEU GLY GLU LEU LEU GLY SEQRES 6 E 90 ARG GLN SER PHE SER VAL LYS ASP PRO SER PRO LEU TYR SEQRES 7 E 90 ASP MET LEU ARG LYS ASN LEU VAL THR LEU ALA THR SEQRES 1 F 15 SER GLN GLU THR PHE SER ASP LEU TRP LYS LEU LEU PRO SEQRES 2 F 15 GLU ASN SEQRES 1 G 90 ILE GLN ILE ASN GLN VAL ARG PRO LYS LEU PRO LEU LEU SEQRES 2 G 90 LYS ILE LEU HIS ALA ALA GLY ALA GLN GLY GLU MET PHE SEQRES 3 G 90 THR VAL LYS GLU VAL MET HIS TYR LEU GLY GLN TYR ILE SEQRES 4 G 90 MET VAL LYS GLN LEU TYR ASP GLN GLN GLU GLN HIS MET SEQRES 5 G 90 VAL TYR CYS GLY GLY ASP LEU LEU GLY GLU LEU LEU GLY SEQRES 6 G 90 ARG GLN SER PHE SER VAL LYS ASP PRO SER PRO LEU TYR SEQRES 7 G 90 ASP MET LEU ARG LYS ASN LEU VAL THR LEU ALA THR SEQRES 1 H 15 SER GLN GLU THR PHE SER ASP LEU TRP LYS LEU LEU PRO SEQRES 2 H 15 GLU ASN FORMUL 9 HOH *429(H2 O) HELIX 1 1 LYS A 30 ALA A 40 1 11 HELIX 2 2 THR A 48 LYS A 63 1 16 HELIX 3 3 ASP A 79 GLY A 86 1 8 HELIX 4 4 PRO A 95 ASN A 105 1 11 HELIX 5 5 THR B 18 LEU B 25 1 8 HELIX 6 6 LYS C 30 ALA C 40 1 11 HELIX 7 7 THR C 48 LYS C 63 1 16 HELIX 8 8 ASP C 79 GLY C 86 1 8 HELIX 9 9 PRO C 95 LEU C 106 1 12 HELIX 10 10 THR D 18 LYS D 24 1 7 HELIX 11 11 LYS E 30 ALA E 40 1 11 HELIX 12 12 THR E 48 LYS E 63 1 16 HELIX 13 13 ASP E 79 GLY E 86 1 8 HELIX 14 14 PRO E 95 LEU E 106 1 12 HELIX 15 15 THR F 18 LEU F 25 1 8 HELIX 16 16 LYS G 30 ALA G 40 1 11 HELIX 17 17 THR G 48 LYS G 63 1 16 HELIX 18 18 ASP G 79 GLY G 86 1 8 HELIX 19 19 PRO G 95 ASN G 105 1 11 HELIX 20 20 THR H 18 LEU H 25 1 8 SHEET 1 A 2 VAL A 27 PRO A 29 0 SHEET 2 A 2 LEU A 106 THR A 108 -1 O VAL A 107 N ARG A 28 SHEET 1 B 2 MET A 73 TYR A 75 0 SHEET 2 B 2 SER A 89 SER A 91 -1 O PHE A 90 N VAL A 74 SHEET 1 C 2 MET C 73 TYR C 75 0 SHEET 2 C 2 SER C 89 SER C 91 -1 O PHE C 90 N VAL C 74 SHEET 1 D 2 MET E 73 TYR E 75 0 SHEET 2 D 2 SER E 89 SER E 91 -1 O PHE E 90 N VAL E 74 SHEET 1 E 2 VAL G 27 PRO G 29 0 SHEET 2 E 2 LEU G 106 THR G 108 -1 O VAL G 107 N ARG G 28 SHEET 1 F 2 MET G 73 TYR G 75 0 SHEET 2 F 2 SER G 89 SER G 91 -1 O PHE G 90 N VAL G 74 CRYST1 36.730 58.870 96.110 90.00 92.00 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027226 0.000000 0.000949 0.00000 SCALE2 0.000000 0.016987 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010411 0.00000